A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women
Authors:
- Kathrin HillmannKHKathrin Hillmann
- Ekkehart DietzEDEkkehart Dietz
- Douglas CanfieldDCDouglas Canfield
- Natalie Garcia BartelsNBNatalie Garcia Bartels
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 65 (6) , 1126-1134.e2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitroJournal of Pharmaceutical Sciences, 2010
- The clinical evaluation of hirsutismDermatologic Therapy, 2008
- A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in menJournal of the American Academy of Dermatology, 2007
- Follicular Penetration of Topically Applied Caffeine via a Shampoo FormulationSkin Pharmacology and Physiology, 2007
- Skin‐sensitizing and irritant properties of propylene glycolContact Dermatitis, 2005
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossJournal of the American Academy of Dermatology, 2004
- Minoxidil: mechanisms of action on hair growthBritish Journal of Dermatology, 2004
- USE OF TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA IN WOMENInternational Journal of Dermatology, 1993
- The safety of topical minoxidil solution in the treatment of pattern baldness: The results of a 27-center trialClinics in Dermatology, 1988
- Patterned androgenic alopecia in womenJournal of the American Academy of Dermatology, 1988